In the era of digital health transformation, the availability of patient data from hospitals…

Health Technology Assessment (HTA) of medical devices is perceived in Europe…

Managed entry agreements (MEA) are arrangements that address…

Before any health-economic assessment, it is necessary…

Rare diseases are a group of diverse diseases that affects a small number of people…

Ensuring that a newly registered drug reaches as many as possible benefiting…

Face-to-face meetings with doctors have long been the preferred way for pharma…

‘How much investment should marketing make in advancing its capabilities?’ is a fair question.

Innovative treatment is often only available upon approval of the application by the medical examiner…